To conclude, both KAT6A and KAT6B have a crucial impact on the tumor proliferation, metastasis, and drug resistance of multiple types of cancers, via regulating the PI3K/AKT signaling axis, the ER signaling pathway, and cell cycle‐related pathways. The gene discussed is AKT1; the disease is neoplasm.